TERN
← all insidersOpen-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON
No open-market insider trades stored for TERN in the last 90 days. The full filing history below may still show grants, exercises, or older activity.
Recent filings
How to read this
- Filed
- Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
- Ticker
- The issuer's stock symbol. Select it to open that company's insider-activity page.
- Issuer
- The company whose shares were traded.
- Sector
- The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
- Insider
- The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
- Role
- The insider's relationship to the company: director, officer, or 10% owner.
- Code
- SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
- Side
- Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
- 10b5-1
- Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
- Shares
- Number of shares in this transaction.
- Price
- Reported price per share. Blank for grants, gifts, and other trades with no stated price.
- Value
- Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
- Owned after
- Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
- Own Δ
- How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
- Co. Δ
- Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
- D/I
- Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
- Lag
- Days from the trade date to the filing date (Form 4 is due within 2 business days).
Transaction codes
Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.
- P
- Open market or private purchase of non-derivative or derivative security
- S
- Open market or private sale of non-derivative or derivative security
- A
- Grant, award or other acquisition pursuant to Rule 16b-3(d)
- D
- Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
- F
- Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
- M
- Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
- G
- Bona fide gift
- C
- Conversion of derivative security
- X
- Exercise of in-the-money or at-the-money derivative security
- J
- Other acquisition or disposition (describe transaction)
| Filed ↓Date the Form 4 was filed with the SEC (due within 2 business days of the trade). | Insider | Role | CodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S). | SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼). | Shares | PriceReported price per share. Blank for trades with no stated price. | ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ). | Owned afterShares the insider held (directly or indirectly) immediately after this trade. | Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing. | Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable. | Link to SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | Tripuraneni Radhika | Director | D | ▼ sell | 1,697→ 1,697 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Tripuraneni Radhika | Director | D | ▼ sell | 32,000→ 32,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Tripuraneni Radhika | Director | D | ▼ sell | 32,000→ 32,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Tripuraneni Radhika | Director | D | ▼ sell | 4,676→ 4,676 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Tripuraneni Radhika | Director | D | ▼ sell | 10,657→ 10,657 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Tripuraneni Radhika | Director | D | ▼ sell | 45,000→ 45,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Tripuraneni Radhika | Director | D | ▼ sell | 64,000→ 64,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Turner Heather D | Director | D | ▼ sell | 1,697→ 1,697 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Turner Heather D | Director | D | ▼ sell | 64,000→ 64,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Turner Heather D | Director | D | ▼ sell | 45,000→ 45,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Quigley Jill M. | Director | D | ▼ sell | 1,697→ 1,697 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Quigley Jill M. | Director | D | ▼ sell | 32,000→ 32,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Quigley Jill M. | Director | D | ▼ sell | 22,000→ 22,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Quigley Jill M. | Director | D | ▼ sell | 3,955→ 3,955 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Quigley Jill M. | Director | D | ▼ sell | 32,000→ 32,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Quigley Jill M. | Director | D | ▼ sell | 10,657→ 10,657 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Quigley Jill M. | Director | D | ▼ sell | 45,000→ 45,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Kuriakose Emil | Officer (Chief Medical Officer) | D | ▼ sell | 112,500→ 112,500 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Kuriakose Emil | Officer (Chief Medical Officer) | D | ▼ sell | 280,000→ 280,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Kuriakose Emil | Officer (Chief Medical Officer) | D | ▼ sell | 120,000→ 120,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Kuriakose Emil | Officer (Chief Medical Officer) | D | ▼ sell | 117,500→ 117,500 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Kuriakose Emil | Officer (Chief Medical Officer) | D | ▼ sell | 485,000→ 485,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Kuriakose Emil | Officer (Chief Medical Officer) | D | ▼ sell | 81,9530 | $53.00 | $4.34M | 0 | −100% | −0.07% (now 0%) | filing |
| 2026-05-05 | Kuriakose Emil | Officer (Chief Medical Officer) | U | ▼ sell | 24,5620 | $53.00 | $1.30M | 0 | −100% | −0.02% (now 0%) | filing |
| 2026-05-05 | KINDLER JEFFREY B | Director | D | ▼ sell | 1,697→ 1,697 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | KINDLER JEFFREY B | Director | D | ▼ sell | 32,000→ 32,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | KINDLER JEFFREY B | Director | D | ▼ sell | 22,000→ 22,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | KINDLER JEFFREY B | Director | D | ▼ sell | 28,475→ 28,475 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | KINDLER JEFFREY B | Director | D | ▼ sell | 32,000→ 32,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | KINDLER JEFFREY B | Director | D | ▼ sell | 4,676→ 4,676 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | KINDLER JEFFREY B | Director | D | ▼ sell | 10,657→ 10,657 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | KINDLER JEFFREY B | Director | D | ▼ sell | 45,000→ 45,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | KINDLER JEFFREY B | Director | D | ▼ sell | 32,000→ 32,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Gengos Andrew | Officer (Chief Financial Officer) | D | ▼ sell | 137,500→ 137,500 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Gengos Andrew | Officer (Chief Financial Officer) | D | ▼ sell | 750,000→ 750,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Gengos Andrew | Officer (Chief Financial Officer) | D | ▼ sell | 68,7500 | $53.00 | $3.64M | 0 | −100% | −0.06% (now 0%) | filing |
| 2026-05-05 | Gengos Andrew | Officer (Chief Financial Officer) | U | ▼ sell | 40,5030 | $53.00 | $2.15M | 0 | −100% | −0.04% (now 0%) | filing |
| 2026-05-05 | FELLOWS DAVID A | Director | D | ▼ sell | 2,828→ 2,828 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | FELLOWS DAVID A | Director | D | ▼ sell | 32,000→ 32,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | FELLOWS DAVID A | Director | D | ▼ sell | 22,000→ 22,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | FELLOWS DAVID A | Director | D | ▼ sell | 28,475→ 28,475 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | FELLOWS DAVID A | Director | D | ▼ sell | 32,000→ 32,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | FELLOWS DAVID A | Director | D | ▼ sell | 8,183→ 8,183 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | FELLOWS DAVID A | Director | D | ▼ sell | 18,650→ 18,650 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | FELLOWS DAVID A | Director | D | ▼ sell | 45,000→ 45,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | FELLOWS DAVID A | Director | D | ▼ sell | 32,000→ 32,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Burroughs Amy L. | Director, Officer (Chief Executive Officer) | D | ▼ sell | 300,000→ 300,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Burroughs Amy L. | Director, Officer (Chief Executive Officer) | D | ▼ sell | 1,250,000→ 1,250,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Burroughs Amy L. | Director, Officer (Chief Executive Officer) | D | ▼ sell | 955,534→ 955,534 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Burroughs Amy L. | Director, Officer (Chief Executive Officer) | D | ▼ sell | 150,0000 | $53.00 | $7.95M | 0 | −100% | −0.13% (now 0%) | filing |
| 2026-05-05 | Burroughs Amy L. | Director, Officer (Chief Executive Officer) | U | ▼ sell | 8,3190 | $53.00 | $440.9K | 0 | −100% | −<0.01% (now 0%) | filing |
| 2026-05-05 | Burroughs Amy L. | Director, Officer (Chief Executive Officer) | U | ▼ sell | 146,6140 | $53.00 | $7.77M | 0 | −100% | −0.13% (now 0%) | filing |
| 2026-05-05 | Azelby Robert | Director | D | ▼ sell | 1,697→ 1,697 Common Stock | — | — | 0 | — | — | filing |
| 2026-05-05 | Azelby Robert | Director | D | ▼ sell | 90,000→ 90,000 Common Stock | — | — | 0 | — | — | filing |
| 2026-04-02 | Kuriakose Emil | Officer (Chief Medical Officer) | S | ▼ sell | 9420 | $52.75 | $49.7K | 105,673 | −0.9% | −<0.01% (now 0.09%) | filing |
Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.